UNITED THERAPEUTICS Corp (UTHR) SEC Filings & Financial Intelligence
UNITED THERAPEUTICS Corp (UTHR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: UTHR
CIK: 1082554
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerStephen Simpson
Audit LocationTysons, Virginia, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-06 | 2026-11-05 | PRIMARY DOCUMENT | 0001106578-26-000182 | View SEC Doc Filr Page |
| 4 | 2026-11-06 | 2026-11-05 | PRIMARY DOCUMENT | 0001106578-26-000181 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-04 | PRIMARY DOCUMENT | 0001106578-26-000180 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-04 | PRIMARY DOCUMENT | 0001106578-26-000179 | View SEC Doc Filr Page |
| 4 | 2026-11-05 | 2026-11-05 | PRIMARY DOCUMENT | 0001231589-26-000023 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001950047-26-010730 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-11-04 | — | SCHEDULE 13G/A Filing | 0001104659-26-122747 | View SEC Doc Filr Page |
| 4 | 2026-11-04 | 2026-11-03 | PRIMARY DOCUMENT | 0001106578-26-000178 | View SEC Doc Filr Page |
| 8-K | 2026-11-04 | 2026-11-04 | 8-K | 0001082554-26-000036 | View SEC Doc Filr Page |
| 10-Q | 2026-11-04 | 2026-09-30 | 10-Q | 0001082554-26-000035 | View SEC Doc Filr Page |
| 4 | 2026-11-03 | 2026-11-02 | PRIMARY DOCUMENT | 0001106578-26-000177 | View SEC Doc Filr Page |
| 144 | 2026-11-02 | — | 144 Filing | 0001950047-26-010587 | View SEC Doc Filr Page |
| 4 | 2026-11-02 | 2026-10-30 | PRIMARY DOCUMENT | 0001106578-26-000176 | View SEC Doc Filr Page |
| 4 | 2026-10-30 | 2026-10-29 | PRIMARY DOCUMENT | 0001106578-26-000175 | View SEC Doc Filr Page |
| 4 | 2026-10-29 | 2026-10-28 | PRIMARY DOCUMENT | 0001106578-26-000174 | View SEC Doc Filr Page |
| 4 | 2026-10-28 | 2026-10-27 | PRIMARY DOCUMENT | 0001106578-26-000173 | View SEC Doc Filr Page |
| 4 | 2026-10-27 | 2026-10-26 | PRIMARY DOCUMENT | 0001106578-26-000172 | View SEC Doc Filr Page |
| 4 | 2026-10-26 | 2026-10-23 | PRIMARY DOCUMENT | 0001106578-26-000171 | View SEC Doc Filr Page |
| 4 | 2026-10-23 | 2026-10-22 | PRIMARY DOCUMENT | 0001106578-26-000170 | View SEC Doc Filr Page |
| 4 | 2026-10-22 | 2026-10-21 | PRIMARY DOCUMENT | 0001106578-26-000169 | View SEC Doc Filr Page |
| 8-K | 2026-10-22 | 2026-10-21 | FORM 8-K | 0001104659-26-117964 | View SEC Doc Filr Page |
| 4 | 2026-10-21 | 2026-10-20 | PRIMARY DOCUMENT | 0001106578-26-000168 | View SEC Doc Filr Page |
| 4 | 2026-10-20 | 2026-10-19 | PRIMARY DOCUMENT | 0001106578-26-000167 | View SEC Doc Filr Page |
| 4 | 2026-10-19 | 2026-10-16 | PRIMARY DOCUMENT | 0001106578-26-000166 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-10-15 | PRIMARY DOCUMENT | 0001106578-26-000165 | View SEC Doc Filr Page |